| Year |
Citation |
Score |
| 2020 |
Grady LL, Klein J, Patterson A, Pompos C, Reich RR, Mason TM. Another Tool on Your Assessment Belt - Using the Orthostatic Algorithm© to Reduce Patient Falls Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.043 |
0.33 |
|
| 2017 |
Klein J, Patterson A, Jepsen A, Badgero K, Moore M, Warrell WA, Thornton K. Effectiveness of Heparin Versus Saline Flushing for Managing Central Venous Catheters (CVCs) in the Blood and Marrow Transplant (BMT) Patients: A Pilot Study Biology of Blood and Marrow Transplantation. 23. DOI: 10.1016/J.Bbmt.2016.12.608 |
0.405 |
|
| 2016 |
Kumar R, Kimura F, Ahn KW, Hu ZH, Kuwatsuka Y, Klein JP, Pasquini M, Miyamura K, Kato K, Yoshimi A, Inamoto Y, Ichinohe T, Wood WA, Wirk B, Seftel M, et al. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26797402 DOI: 10.1016/J.Bbmt.2016.01.012 |
0.472 |
|
| 2015 |
Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang MJ, Carreras J, Montoto S, Perales MA, Aljurf MD, Akpek G, Bredeson CN, Costa LJ, Dandoy C, Freytes CO, Fung HC, et al. The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 25981509 DOI: 10.1016/J.Bbmt.2015.05.010 |
0.471 |
|
| 2015 |
Arora M, Hemmer MT, Ahn KW, Klein JP, Cutler CS, Urbano-Ispizua A, Couriel DR, Alousi AM, Gale RP, Inamoto Y, Weisdorf DJ, Li P, Antin JH, Bolwell BJ, Boyiadzis M, et al. Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 640-5. PMID 25528390 DOI: 10.1016/J.Bbmt.2014.10.022 |
0.489 |
|
| 2015 |
Boyiadzis M, Arora M, Klein JP, Hassebroek A, Hemmer M, Urbano-Ispizua A, Antin JH, Bolwell BJ, Cahn JY, Cairo MS, Cutler CS, Flowers ME, Gale RP, Herzig R, Isola LM, et al. Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2020-8. PMID 25348512 DOI: 10.1158/1078-0432.Ccr-14-0586 |
0.479 |
|
| 2014 |
DE Castro M, Chen MH, Ibrahim JG, Klein JP. Bayesian Transformation Models for Multivariate Survival Data. Scandinavian Journal of Statistics, Theory and Applications. 41: 187-199. PMID 24904194 DOI: 10.1111/Sjos.12010 |
0.364 |
|
| 2014 |
Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Marsh SG, Spellman S, Haagenson MD, Saeturn K, Ladner M, Trachtenberg E, Parham P, Miller JS. Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia. Journal of Immunology (Baltimore, Md. : 1950). 192: 4592-600. PMID 24748496 DOI: 10.4049/Jimmunol.1302517 |
0.442 |
|
| 2014 |
Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M, Fernandez-Vina MA, Freeman J, He W, Iori AP, Horowitz MM, et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood. 123: 133-40. PMID 24141369 DOI: 10.1182/Blood-2013-05-506253 |
0.369 |
|
| 2014 |
Mendolia F, Klein JP, Petersdorf EW, Malkki M, Wang T. Comparison of statistics in association tests of genetic markers for survival outcomes. Statistics in Medicine. 33: 828-44. PMID 24105914 DOI: 10.1002/Sim.5982 |
0.748 |
|
| 2014 |
Hong S, Rademacher JL, Carreras J, Kroll TM, Klein JP, Pasquini MC. Comparison of Fludarabine and Total Body Irradiation (FluTBI) to Fludarabine without TBI (Flu) Based Nonmyeloabltive Conditioning (NMA) Prior to Hematopoietic Cell Transplantation (HCT) for Lymphoma Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.387 |
0.43 |
|
| 2013 |
Fernández-Viña MA, Klein JP, Haagenson M, Spellman SR, Anasetti C, Noreen H, Baxter-Lowe LA, Cano P, Flomenberg N, Confer DL, Horowitz MM, Oudshoorn M, Petersdorf EW, Setterholm M, Champlin R, et al. Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. Blood. 121: 4603-10. PMID 23596045 DOI: 10.1182/Blood-2013-02-481945 |
0.478 |
|
| 2013 |
Klein JP, Hemmer MT, Li P, Cutler CS, Urbano-Ispizua A, Couriel DR, Gale RP, Inamoto Y, Antin JH, Bolwell BJ, Boyiadzis M, MHSc, Cahn J, Cairo MS, Isola LM, et al. The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort Blood. 122: 706-706. DOI: 10.1182/Blood.V122.21.706.706 |
0.45 |
|
| 2013 |
Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Marsh SG, Spellman S, Haagenson MD, Saeturn K, Ladner M, Trachtenberg E, Parham P, Miller JS. Recipient HLA-C1 Enhances The Clinical Advantage Of Killer-Cell Immunoglobulin-Like Receptor B haplotype Donors In Myeloablative Unrelated Transplantation For Acute Myelogenous Leukemia Blood. 122: 549-549. DOI: 10.1182/Blood.V122.21.549.549 |
0.453 |
|
| 2013 |
Kollman C, Klein JP, Spellman SR, Hassebroek A, Confer D, Fernandez-Vina M, Hartzman R, Hurley CK, Maiers M, Mueller CR, Setterholm M, Woolfrey A, Yu N, Eapen M. The Effect of Donor Characteristics On Graft Vs. Host Disease (GVHD) and Survival After Unrelated Donor Transplantation for Hematologic Malignancy Biology of Blood and Marrow Transplantation. 19. DOI: 10.1016/J.Bbmt.2012.11.095 |
0.467 |
|
| 2012 |
Martin EF, Huang J, Xiang Q, Klein JP, Bajaj J, Saeian K. Recipient survival and graft survival are not diminished by simultaneous liver-kidney transplantation: an analysis of the united network for organ sharing database. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 18: 914-29. PMID 22467623 DOI: 10.1002/Lt.23440 |
0.448 |
|
| 2012 |
Pearce KF, Lee SJ, Haagenson M, Petersdorf EW, Norden J, Collin MP, Klein JP, Spellman SR, Lowerson SA, Davies S, Dickinson AM. Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia. Haematologica. 97: 1014-9. PMID 22271889 DOI: 10.3324/Haematol.2011.053611 |
0.502 |
|
| 2012 |
Cohen EP, Bedi M, Irving AA, Jacobs E, Tomic R, Klein J, Lawton CA, Moulder JE. Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation. International Journal of Radiation Oncology, Biology, Physics. 83: 292-6. PMID 22104363 DOI: 10.1016/J.Ijrobp.2011.05.081 |
0.363 |
|
| 2012 |
Ballen KK, Klein JP, Pedersen TL, Bhatla D, Duerst R, Kurtzberg J, Lazarus HM, LeMaistre CF, McCarthy P, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, et al. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 903-12. PMID 22062801 DOI: 10.1016/J.Bbmt.2011.10.040 |
0.428 |
|
| 2012 |
Spellman S, Klein J, Haagenson M, Askar M, Baxter-Lowe LA, He J, Hsu S, Blasczyk R, Hurley C. Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 18: 739-746. PMID 21963622 DOI: 10.1016/J.Bbmt.2011.09.008 |
0.47 |
|
| 2012 |
Marino SR, Lin S, Maiers M, Haagenson M, Spellman S, Klein JP, Binkowski TA, Lee SJ, van Besien K. Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation. Bone Marrow Transplantation. 47: 217-26. PMID 21441965 DOI: 10.1038/Bmt.2011.56 |
0.406 |
|
| 2012 |
Wang H, Klein J. Semiparametric Estimation for the Additive Inverse Gaussian Frailty Model Communications in Statistics - Theory and Methods. 41: 2269-2278. DOI: 10.1080/03610926.2011.560735 |
0.343 |
|
| 2012 |
Barker CA, Hong S, Klein JP, Shaw P, Bredeson C, Angelina A, Rowlings P, Cahn J-, Kharfan-Dabaja M, Aljurf M, Szer J, Wood WA, Ahmed I, Almaguer DG, Atsuta Y, et al. Radiotherapeutic Techniques in Allogeneic Hematopoietic Cell Transplant (HCT) Biology of Blood and Marrow Transplantation. 18. DOI: 10.1016/J.Bbmt.2011.12.388 |
0.425 |
|
| 2012 |
Hong S, Barker C, Klein JP, Shaw P, Bredeson C, Angelina A, Rowlings P, Cahn J-, Dabaja K, Aljurf M, Szer J, Wood WA, Ahmed I, Gomez-Almaguer D, Atsuta Y, et al. Trends in Utilization of Total Body Irradiation (TBI) Prior to Hematopoietic Cell Transplantation (HCT) Worldwide Biology of Blood and Marrow Transplantation. 18. DOI: 10.1016/J.Bbmt.2011.12.348 |
0.427 |
|
| 2012 |
Tomblyn M, Trifilio S, Chen M, Klein J, Boeckh M, Gea-Banacloche J, Szabolcs P, Bennett C. Risk Factors and Outcomes in Patients with Atypical Mold Infection (AMI) Following Allogeneic Hematopoietic Cell Transplantation (HCT): A CIBMTR Analysis from the Infection and Immune Reconstitution Working Committee Biology of Blood and Marrow Transplantation. 18. DOI: 10.1016/J.Bbmt.2011.12.102 |
0.38 |
|
| 2012 |
Boyiadzis M, Klein JP, Arora M, Weisdorf DJ, Hassebroek A, Lee SJ, Flowers ME, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Cahn J-, Cairo MS, Gale RP, Herzig RH, et al. Impact of Chronic GVHD on Late Relapse, Treatment Related Mortality and Survival After Allogeneic Hematopoietic Cell Transplantation for Hematological Malignancies Biology of Blood and Marrow Transplantation. 18. DOI: 10.1016/J.Bbmt.2011.12.021 |
0.459 |
|
| 2011 |
Tunes-da-Silva G, Klein JP. Cutpoint selection for discretizing a continuous covariate for generalized estimating equations. Computational Statistics & Data Analysis. 55: 226-235. PMID 22639478 DOI: 10.1016/J.Csda.2010.02.016 |
0.414 |
|
| 2011 |
Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, Brown M, Champlin RE, Garcia-Lopez J, Hattersely G, Koegler G, Laughlin MJ, Michel G, Nabhan SK, Smith FO, et al. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. The Lancet. Oncology. 12: 1214-21. PMID 21982422 DOI: 10.1016/S1470-2045(11)70260-1 |
0.445 |
|
| 2011 |
Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Bolwell BJ, Antin JH, Boyiadzis M, Cahn JY, Cairo MS, Herzig RH, Isola LM, Klumpp TR, et al. Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood. 118: 4472-9. PMID 21878671 DOI: 10.1182/Blood-2011-04-349068 |
0.491 |
|
| 2011 |
Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola L, Jacobsohn DA, Jagasia M, et al. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. Blood. 117: 6714-20. PMID 21493797 DOI: 10.1182/Blood-2010-12-323824 |
0.483 |
|
| 2011 |
Woolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M, Gajewski J, Hale GA, Horan J, Battiwalla M, Marino SR, Setterholm M, Ringden O, Hurley C, Flomenberg N, et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 885-92. PMID 20870028 DOI: 10.1016/J.Bbmt.2010.09.012 |
0.436 |
|
| 2011 |
Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD. High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR. Bone Marrow Transplantation. 46: 385-92. PMID 20479710 DOI: 10.1038/Bmt.2010.115 |
0.428 |
|
| 2011 |
Logan BR, Zhang MJ, Klein JP. Marginal models for clustered time-to-event data with competing risks using pseudovalues. Biometrics. 67: 1-7. PMID 20377579 DOI: 10.1111/J.1541-0420.2010.01416.X |
0.319 |
|
| 2010 |
Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, Kamble R, Copelan E, de Lima M, Gupta V, Keating A, Lazarus HM, Litzow MR, Marks DI, Maziarz RT, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3730-8. PMID 20625136 DOI: 10.1200/Jco.2010.28.8852 |
0.45 |
|
| 2010 |
Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, Marsh SG, Geraghty D, Spellman S, Haagenson MD, Ladner M, Trachtenberg E, Parham P, Miller JS. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 116: 2411-9. PMID 20581313 DOI: 10.1182/Blood-2010-05-283051 |
0.483 |
|
| 2010 |
Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, Rizzo JD. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1888-95. PMID 20212247 DOI: 10.1200/Jco.2009.26.7757 |
0.447 |
|
| 2010 |
Tomblyn M, Young JA, Haagenson MD, Klein JP, Trachtenberg EA, Storek J, Spellman SR, Cooley S, Miller JS, Weisdorf DJ. Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 1155-61. PMID 20197104 DOI: 10.1016/J.Bbmt.2010.02.024 |
0.384 |
|
| 2010 |
Loberiza FR, Lee SJ, Klein JP, Hassebroek A, Dehn JG, Frangoul HA, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Maziarz RT, Rizzo JD, Majhail NS. Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 368-75. PMID 19879951 DOI: 10.1016/J.Bbmt.2009.10.028 |
0.425 |
|
| 2010 |
Arora M, Klein JP, Antin JH, Bolwell BJ, Boyiadzis M, Cahn J, Cairo MS, Cutler CS, Flowers ME, Gale RP, Hassebroek A, Herzig RH, Horowitz MM, Isola L, Jacobsohn DA, et al. Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis Blood. 116: 898-898. DOI: 10.1182/Blood.V116.21.898.898 |
0.42 |
|
| 2010 |
Hahn T, McCarthy PL, Hassebroek A, Klein JP, Rizzo JD, Parsons S, Joffe S, Majhail NS. Significant Improvement In Day 100 and 1-Year Overall Survival In Patients Who Underwent Myeloablative Allogeneic Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005 Blood. 116: 3509-3509. DOI: 10.1182/Blood.V116.21.3509.3509 |
0.482 |
|
| 2010 |
McCarthy PL, Hahn T, Hassebroek A, Klein JP, Rizzo JD, Parsons S, Joffe S, Majhail NS. Significant Improvement In Overall Survival In Patients Who Underwent Autologous Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005 Blood. 116: 2389-2389. DOI: 10.1182/Blood.V116.21.2389.2389 |
0.452 |
|
| 2010 |
Ballen KK, Klein JP, Pedersen TL, Kurtzberg J, Lazarus HM, LeMaistre CF, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, Rizzo JD, et al. Relationship of Race/Ethnicity and Survival After Single Umbilical Cord Blood Transplantation Blood. 116: 224-224. DOI: 10.1182/Blood.V116.21.224.224 |
0.452 |
|
| 2010 |
Jacobsohn DA, Arora M, Klein JP, Antin JH, Bolwell BJ, Boyiadzis M, Cahn J, Cairo MS, Cutler CS, Flowers ME, Gale RP, Hassebroek A, Herzig RH, Horowitz MM, Isola L, et al. Risk Factors for Major Transplant Related Outcomes In Pediatric Patients with Chronic Graft-Versus-Host Disease Blood. 116: 211-211. DOI: 10.1182/Blood.V116.21.211.211 |
0.424 |
|
| 2010 |
Martin E, Huang J, Klein JP, Xiang Q, Bajaj JS, Saeian K. M1009 The Impact of Combined Liver and Kidney Transplantation on Transplant Outcomes Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)63783-3 |
0.407 |
|
| 2009 |
Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C, Dehn J, Friedman D, Hahn T, Hale G, Lazarus HM, et al. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 1543-54. PMID 19896078 DOI: 10.1016/J.Bbmt.2009.07.023 |
0.455 |
|
| 2009 |
Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL. Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood. 114: 2606-16. PMID 19608747 DOI: 10.1182/Blood-2009-03-208355 |
0.469 |
|
| 2009 |
Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. British Journal of Haematology. 147: 129-39. PMID 19573079 DOI: 10.1111/J.1365-2141.2009.07798.X |
0.45 |
|
| 2009 |
Arora M, Weisdorf DJ, Spellman SR, Haagenson MD, Klein JP, Hurley CK, Selby GB, Antin JH, Kernan NA, Kollman C, Nademanee A, McGlave P, Horowitz MM, Petersdorf EW. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1644-52. PMID 19224849 DOI: 10.1200/Jco.2008.18.7740 |
0.529 |
|
| 2009 |
Tunes-da-Silva G, Klein JP. Regression analysis of mean quality-adjusted survival time based on pseudo-observations. Statistics in Medicine. 28: 1054-66. PMID 19205073 DOI: 10.1002/Sim.3529 |
0.33 |
|
| 2009 |
Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 113: 3604-11. PMID 19190248 DOI: 10.1182/Blood-2008-08-175323 |
0.423 |
|
| 2009 |
Tunes da Silva G, Logan BR, Klein JP. Methods for equivalence and noninferiority testing. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 120-7. PMID 19147090 DOI: 10.1016/J.Bbmt.2008.10.004 |
0.358 |
|
| 2009 |
Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, Marsh SG, Guethlein LA, Parham P, Miller JS, Weisdorf DJ. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood. 113: 726-32. PMID 18945962 DOI: 10.1182/Blood-2008-07-171926 |
0.493 |
|
| 2009 |
Cooley S, Guethlein L, Trachtenberg E, Ladner M, Luo X, Le CT, Wang T, Klein JP, Marsh SG, Spellman S, Haagenson MD, Weisdorf DJ, Parham P, Miller JS. Selection of Donors with Favorable KIR B Genotypes for Unrelated Hematopoietic Cell Transplantation Results in Superior Relapse Protection and Better Relapse-Free Survival for Patients with AML. Blood. 114: 665-665. DOI: 10.1182/Blood.V114.22.665.665 |
0.388 |
|
| 2009 |
Duval M, He W, Klein JP, Tallman MS, DiPersio JF, Bunjes DW, Weisdorf DJ. Allogeneic Hematopoietic Cell Transplantation Can Cure Some Patients with Acute Leukemia in Relapse or Primary Induction Failure: A CIBMTR Study. Blood. 114: 528-528. DOI: 10.1182/Blood.V114.22.528.528 |
0.496 |
|
| 2009 |
Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, Rizzo JD. Long-Term Survival and Late Relapse in 5-Year Survivors of Allogeneic Hematopoietic-Cell Transplantation (HCT) for Chronic Myeloid Leukemia (CML) in First Chronic Phase. Blood. 114: 3321-3321. DOI: 10.1182/Blood.V114.22.3321.3321 |
0.459 |
|
| 2009 |
Shaw PJ, Kan F, Ahn KW, Spellman SR, Davies SM, Pulsipher MA, Petersdorf EW, Klein J, Lee SJ. Pediatric BMT for Malignancy Using Zero/One Antigen Mismatched Family Donors or Unrelated Donors Have Similar Outcomes, Both of Which Are Inferior to Matched Sibling Donors8 Biology of Blood and Marrow Transplantation. 15: 4. DOI: 10.1016/J.Bbmt.2008.12.012 |
0.374 |
|
| 2009 |
Cooley S, Parham P, Trachtenberg E, Luo X, Le C, Klein J, Marsh S, Weisdorf D, Miller J. The Relapse-Free Survival Benefit Associated with Group B KIR Haplotype Donors for Unrelated Hematopoietic Cell Transplantation is Unique to Acute Myelogenous Leukemia Biology of Blood and Marrow Transplantation. 15: 3. DOI: 10.1016/J.Bbmt.2008.12.010 |
0.47 |
|
| 2008 |
Klein JP, Zhang MJ. Guest editor introduction to issue on transplant statistics. Lifetime Data Analysis. 14: 377-8. PMID 18949557 DOI: 10.1007/S10985-008-9103-3 |
0.505 |
|
| 2008 |
Logan BR, Nelson GO, Klein JP. Analyzing center specific outcomes in hematopoietic cell transplantation. Lifetime Data Analysis. 14: 389-404. PMID 18836830 DOI: 10.1007/S10985-008-9100-6 |
0.484 |
|
| 2008 |
Liu L, Logan B, Klein JP. Inference for current leukemia free survival. Lifetime Data Analysis. 14: 432-46. PMID 18663574 DOI: 10.1007/S10985-008-9093-1 |
0.503 |
|
| 2008 |
Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C, Setterholm M, Drexler R, Maiers M, King R, Confer D, Klein J. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 748-58. PMID 18541193 DOI: 10.1182/Blood.V110.11.45.45 |
0.461 |
|
| 2008 |
Perez-Albuerne ED, Eapen M, Klein J, Gross TJ, Lipton JM, Baker KS, Woolfrey A, Kamani N. Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. British Journal of Haematology. 141: 216-23. PMID 18307564 DOI: 10.1111/J.1365-2141.2008.07030.X |
0.488 |
|
| 2008 |
Klein JP, Gerster M, Andersen PK, Tarima S, Perme MP. SAS and R functions to compute pseudo-values for censored data regression. Computer Methods and Programs in Biomedicine. 89: 289-300. PMID 18199521 DOI: 10.1016/J.Cmpb.2007.11.017 |
0.356 |
|
| 2008 |
Logan BR, Klein JP, Zhang MJ. Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. Biometrics. 64: 733-40. PMID 18190619 DOI: 10.1111/J.1541-0420.2007.00975.X |
0.435 |
|
| 2008 |
Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, Juckett MB, Moulder JE. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. International Journal of Radiation Oncology, Biology, Physics. 70: 1546-51. PMID 18029109 DOI: 10.1016/J.Ijrobp.2007.08.041 |
0.366 |
|
| 2008 |
Laport G, Bredeson C, Tomblyn MR, Kahl BS, Goodman SA, Ewell M, Klein J, Horowitz MM, Vose JM, Negrin RS. Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with follicular non-hodgkins lymphoma (FL) beyond first complete response or first partial response Journal of Clinical Oncology. 26: 7041-7041. DOI: 10.1200/Jco.2008.26.15_Suppl.7041 |
0.448 |
|
| 2008 |
Woolfrey AE, Klein J, Haagenson MD, Spellman SR, Battiwalla M, Gajewski JL, Hale GA, Horan J, Hurley CK, Kollman C, Marino S, Oudshoorn M, Petersdorf EW, Ringdén O, Setterholm M, et al. Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation Blood. 112: 563-563. DOI: 10.1182/blood.v112.11.563.563 |
0.352 |
|
| 2008 |
Fernandez-Vina M, Klein J, Haagenson MD, Spellman SR, Lee SJ, Anasetti C, Baxter-Lowe LA, Cano P, Flomenberg N, Horowitz MM, Hurley CK, Oudshoorn M, Petersdorf EW, Setterholm M, Champlin R, et al. The Clinical Significance of Matching for Alleles at the Low Expression HLA Loci DP, DQ and DRB3/4/5 in Unrelated Hematopoietic Stem Cell Transplantation Blood. 112: 561-561. DOI: 10.1182/Blood.V112.11.561.561 |
0.479 |
|
| 2008 |
Tomblyn M, Young J, Haagenson MD, Klein JP, Storek J, Spellman S, Cooley S, Weisdorf DJ, Miller JS. Decreased Infections in Recipients of Unrelated Donor (URD Hematopoietic Cell Transplantation (HCT) from Donors with An Activating KIR B Genotype (B/x) Blood. 112: 351-351. DOI: 10.1182/Blood.V112.11.351.351 |
0.424 |
|
| 2008 |
Marino S, Lin S, Maiers M, Haagenson MD, Spellman SR, Lee SJ, Wang T, Klein J, Besien KV. Identifying Amino Acid Substitution Positions Associated with Day 100 Survival in Unrelated Donor Stem Cell Transplant Using Random Forest Analysis Blood. 112: 3012-3012. DOI: 10.1182/Blood.V112.11.3012.3012 |
0.385 |
|
| 2008 |
Eapen M, Klein J, Sanz G, Anasetti C, Garcia J, Gluckman E, Horowitz MM, Koegler G, Laughlin M, Michel G, Spellman SR, Smith FO, Rocha V. Donor-Recipient Matching at the HLA-C Locus and Early Outcomes after Unrelated Umbilical Cord Blood Transplant (UCBT) Blood. 112: 153-153. DOI: 10.1182/Blood.V112.11.153.153 |
0.466 |
|
| 2008 |
Bajorunaite R, Klein JP. Comparison of failure probabilities in the presence of competing risks Journal of Statistical Computation and Simulation. 78: 951-966. DOI: 10.1080/00949650701473791 |
0.302 |
|
| 2008 |
Zhang X, Loberiza FR, Klein JP, Zhang M. Erratum to “A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model” [Comput. Meth. Prog. Biomed. 88 (2007) 95–101] Computer Methods and Programs in Biomedicine. 89: 313-314. DOI: 10.1016/J.Cmpb.2007.11.003 |
0.325 |
|
| 2008 |
Pulsipher M, Chitphakdithai P, Logan B, Leitman S, Anderlini P, Klein J, Horowitz M, Miller J, King R, Confer D. 40: Outcomes of a Prospective Trial of NMDP-Facilitated Unrelated Donor (UD) PBSC Hematopoietic Cell Transplantation (HCT) for Leukemia and Myelodysplasia: Comparable Survival Regardless of Regimen Intensity and Improved Survival with Higher Cell Doses Biology of Blood and Marrow Transplantation. 14: 17. DOI: 10.1016/J.Bbmt.2007.12.048 |
0.464 |
|
| 2007 |
Spellman S, Bray R, Rosen-Bronson S, Haagenson M, Klein J, Flesch S, Vierra-Green C, Anasetti C. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure Blood. 115: 2704-2708. PMID 20089963 DOI: 10.1182/Blood-2009-09-244525 |
0.486 |
|
| 2007 |
Zhang X, Loberiza FR, Klein JP, Zhang MJ. A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Computer Methods and Programs in Biomedicine. 88: 95-101. PMID 17850917 DOI: 10.1016/J.Cmpb.2007.07.010 |
0.435 |
|
| 2007 |
Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley CK, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 110: 4576-83. PMID 17785583 DOI: 10.1182/Blood-2007-06-097386 |
0.442 |
|
| 2007 |
Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD. Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 778-89. PMID 17580256 DOI: 10.1016/J.Bbmt.2007.02.013 |
0.49 |
|
| 2007 |
Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 369: 1947-54. PMID 17560447 DOI: 10.1016/S0140-6736(07)60915-5 |
0.475 |
|
| 2007 |
Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AV, Socie G, et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood. 110: 1397-400. PMID 17475907 DOI: 10.1182/Blood-2007-03-081596 |
0.511 |
|
| 2007 |
Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP, Hale GA, Horan J, Hows JM, Klein JP, Pasquini R, Roberts I, Sullivan K, Eapen M, Ferster A, et al. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. British Journal of Haematology. 137: 479-85. PMID 17459050 DOI: 10.1111/J.1365-2141.2007.06592.X |
0.51 |
|
| 2007 |
Mehta PA, Eapen M, Klein JP, Gandham S, Elliott J, Zamzow T, Combs M, Aplenc R, MacMillan ML, Weisdorf DJ, Petersdorf E, Davies SM. Interleukin-1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia. British Journal of Haematology. 137: 152-7. PMID 17391495 DOI: 10.1111/J.1365-2141.2007.06552.X |
0.455 |
|
| 2007 |
Klein JP, Logan B, Harhoff M, Andersen PK. Analyzing survival curves at a fixed point in time. Statistics in Medicine. 26: 4505-19. PMID 17348080 DOI: 10.1002/Sim.2864 |
0.415 |
|
| 2007 |
Miller JS, Cooley S, Parham P, Farag SS, Verneris MR, McQueen KL, Guethlein LA, Trachtenberg EA, Haagenson M, Horowitz MM, Klein JP, Weisdorf DJ. Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. Blood. 109: 5058-61. PMID 17317850 DOI: 10.1182/Blood-2007-01-065383 |
0.443 |
|
| 2007 |
Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E, Bredeson CN, Eapen M, Horowitz MM. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood. 109: 4582-5. PMID 17272503 DOI: 10.1182/Blood-2006-10-052308 |
0.479 |
|
| 2007 |
Wade JA, Hurley CK, Takemoto SK, Thompson J, Davies SM, Fuller TC, Rodey G, Confer DL, Noreen H, Haagenson M, Kan F, Klein J, Eapen M, Spellman S, Kollman C. HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. Blood. 109: 4064-70. PMID 17202313 DOI: 10.1182/Blood-2006-06-032193 |
0.466 |
|
| 2007 |
Shu Y, Klein JP, Zhang MJ. Asymptotic theory for the Cox semi-Markov illness-death model. Lifetime Data Analysis. 13: 91-117. PMID 17115258 DOI: 10.1007/S10985-006-9018-9 |
0.552 |
|
| 2007 |
Cooley S, Miller JS, Trachtenberg E, Bergemann T, Saeteurn K, Klein J, Guethlein LA, Marsh SG, Geraghty D, Parham P, Weisdorf D. Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping. Blood. 110: 43-43. DOI: 10.1182/Blood.V110.11.43.43 |
0.483 |
|
| 2007 |
Baker KS, Hassebroek A, Ballen K, Bigelow C, Frangoul H, Hardy C, Lee S, Switzer G, Rizzo JD, Klein JP, Majhail N, Davies S. Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT). Blood. 110: 3064-3064. DOI: 10.1182/Blood.V110.11.3064.3064 |
0.471 |
|
| 2007 |
Arora M, Spellman S, Haagenson M, Klein JP, Hurley C, Selby G, Antin J, Kernan N, Kollman C, Nademanee A, Weisdorf DJ, Horowitz MM, McGlave P, Petersdorf E. High Resolution HLA Matched Unrelated Donor Versus HLA Identical Sibling Transplantation for Chronic Phase CML. Blood. 110: 171-171. DOI: 10.1182/Blood.V110.11.171.171 |
0.509 |
|
| 2007 |
Andersen PK, Klein JP. Regression analysis for multistate models based on a pseudo-value approach, with applications to bone marrow transplantation studies Scandinavian Journal of Statistics. 34: 3-16. DOI: 10.1111/J.1467-9469.2006.00526.X |
0.456 |
|
| 2007 |
Klein JP, Zhang MJ. 9 Survival Analysis Handbook of Statistics. 27: 281-320. DOI: 10.1016/S0169-7161(07)27009-9 |
0.329 |
|
| 2007 |
Bajorunaite R, Klein JP. Two-sample tests of the equality of two cumulative incidence functions Computational Statistics and Data Analysis. 51: 4269-4281. DOI: 10.1016/J.Csda.2006.05.011 |
0.353 |
|
| 2006 |
Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE. Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood. 108: 4288-90. PMID 16946302 DOI: 10.1182/Blood-2006-05-024042 |
0.507 |
|
| 2006 |
Lazarus HM, Pérez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Douglas Rizzo J, Spitzer TR, Weisdorf DJ, et al. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. British Journal of Haematology. 132: 755-69. PMID 16487177 DOI: 10.1111/J.1365-2141.2005.05947.X |
0.495 |
|
| 2006 |
Klein JP. Modelling competing risks in cancer studies. Statistics in Medicine. 25: 1015-34. PMID 16435339 DOI: 10.1002/Sim.2246 |
0.381 |
|
| 2006 |
Logan BR, Zhang MJ, Klein JP. Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 107-12. PMID 16399594 DOI: 10.1016/J.Bbmt.2005.09.005 |
0.432 |
|
| 2006 |
Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer D, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley C, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, et al. Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation. Blood. 108: 172-172. DOI: 10.1182/Blood.V108.11.172.172 |
0.433 |
|
| 2006 |
Miller JS, Cooley S, Parham P, Verneris MR, McQueen K, Guethlein L, Farag S, Haagenson M, Horowitz M, Klein J, Weisdorf DJ. KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD). Blood. 108: 171-171. DOI: 10.1182/Blood.V108.11.171.171 |
0.383 |
|
| 2006 |
Pulsipher M, Chitphakdithai P, Klein J, Kurian S, Leitman S, Anderlini P, Logan B, Horowitz MM, Confer DL. Volunteer Unrelated Donor PBSC Collection Efficacy and Recipient Outcomes: Results of a Prospective National Marrow Donor Program (NMDP) Trial, 1999–2003. Blood. 108: 169-169. DOI: 10.1182/Blood.V108.11.169.169 |
0.432 |
|
| 2005 |
Andersen PK, Ekstrøm CT, Klein JP, Shu Y, Zhang MJ. A class of goodness of fit tests for a copula based on bivariate right-censored data. Biometrical Journal. Biometrische Zeitschrift. 47: 815-24. PMID 16450854 DOI: 10.1002/Bimj.200410163 |
0.565 |
|
| 2005 |
Drygalski AV, Savatski L, Eastwood D, Klein J, Adamson JW. The rate of marrow recovery and extent of donor engraftment following transplantation of ex vivo-expanded bone marrow cells are independently influenced by the cytokines used for expansion. Stem Cells and Development. 14: 564-575. PMID 16305341 DOI: 10.1089/Scd.2005.14.564 |
0.406 |
|
| 2005 |
Santo Tomas LH, Loberiza FR, Klein JP, Layde PM, Lipchik RJ, Rizzo JD, Bredeson CN, Horowitz MM. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest. 128: 153-61. PMID 16002929 DOI: 10.1378/Chest.128.1.153 |
0.5 |
|
| 2005 |
Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH, Leblond V, Ifrah N, Jouet JP, Loberiza F, Ringden O, Barrett AJ, Horowitz MM, Socié G, et al. Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood. 106: 1495-500. PMID 15878974 DOI: 10.1182/Blood-2004-11-4557 |
0.511 |
|
| 2005 |
Bhattacharyya M, Klein JP. A random effects model for multistate survival analysis with application to bone marrow transplants. Mathematical Biosciences. 194: 37-48. PMID 15836863 DOI: 10.1016/J.Mbs.2004.07.005 |
0.424 |
|
| 2005 |
Klein JP, Andersen PK. Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function. Biometrics. 61: 223-9. PMID 15737097 DOI: 10.1111/J.0006-341X.2005.031209.X |
0.404 |
|
| 2005 |
Loberiza FR, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood. 105: 2979-87. PMID 15598815 DOI: 10.1182/Blood-2004-10-3863 |
0.461 |
|
| 2005 |
Rubinstein P, Eapen M, Stevens C, Kurtzberg J, Scaradavou A, Klein J, Horowitz M, Wagner J. Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Leukemia: Risks and Benefits of Umbilical Cord Blood (CB) vs. Bone Marrow (BM). Blood. 106: 302-302. DOI: 10.1182/Blood.V106.11.302.302 |
0.442 |
|
| 2005 |
Mehta PA, Eapen M, Gandham S, Elliott J, Combs M, Wilke T, Aplenc R, MacMillan ML, Weisdorf DJ, Petersdorf EW, Klein J, Davies SM. Interleukin-1 α Genotype and Outcome of Unrelated Donor BMT for CML. Blood. 106: 2057-2057. DOI: 10.1182/Blood.V106.11.2057.2057 |
0.437 |
|
| 2005 |
Shu Y, Klein JP. Additive hazards Markov regression models illustrated with bone marrow transplant data Biometrika. 92: 283-301. DOI: 10.1093/Biomet/92.2.283 |
0.641 |
|
| 2004 |
Stiff PJ, Lazarus HM, Childs RW, Perez W, Carreras J, Klein J, Rizzo DJ. Utility of single vs tandem autotransplants for advanced testes/germ cell cancer: An Autologous Blood and Marrow Transplant Registry (ABMTR) analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4536. PMID 28016049 DOI: 10.1200/Jco.2004.22.14_Suppl.4536 |
0.421 |
|
| 2004 |
Baker KM, Lu L, Klein JP, Cao K, Reiners K, Johnson C, Lipsey J, Hassani S, Ackman JD, Schwab JP, Harris GF. Kinematic analysis of upper extremity joint motion in children using posterior walkers. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 7: 5100-3. PMID 17271465 DOI: 10.1109/IEMBS.2004.1404409 |
0.438 |
|
| 2004 |
Andersen PK, Hansen MG, Klein JP. Regression analysis of restricted mean survival time based on pseudo-observations. Lifetime Data Analysis. 10: 335-50. PMID 15690989 DOI: 10.1007/S10985-004-4771-0 |
0.358 |
|
| 2004 |
Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR, Ringdén O, Wagner JE. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4872-80. PMID 15520055 DOI: 10.1200/Jco.2004.02.189 |
0.497 |
|
| 2004 |
Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplantation. 34: 721-7. PMID 15322568 DOI: 10.1038/Sj.Bmt.1704645 |
0.517 |
|
| 2004 |
Passweg JR, Walker I, Sobocinski KA, Klein JP, Horowitz MM, Giralt SA. Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants. British Journal of Haematology. 125: 613-20. PMID 15147377 DOI: 10.1111/J.1365-2141.2004.04955.X |
0.466 |
|
| 2004 |
Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood. 104: 579-85. PMID 15039286 DOI: 10.1182/Blood-2004-01-0338 |
0.498 |
|
| 2004 |
Loberiza FR, Zhang M, Rizzo JD, Lee SJ, Klein JP, Logan BR, Eapen M, Serna DS, Lemaistre CF, Horowitz MM. Patient and transplant center factors associated with 100D mortality after receiving allogeneic hematopoietic stem cell transplantation (HSCT) Journal of Clinical Oncology. 22: 6026-6026. DOI: 10.1200/Jco.2004.22.90140.6026 |
0.422 |
|
| 2004 |
Wall D, Wagner J, Laughlin M, Ballen K, Staba S, Chan KW, McGaha O, Logan B, Klein J, Arora M. Higher Cell Dose and CD34+ Content Improves Engraftment Following Unrelated Donor Cord Blood Transplantation (CBT): A Report of the National Marrow Donor Program (NMDP) Cord Blood (CB) Experience. Blood. 104: 975-975. DOI: 10.1182/Blood.V104.11.975.975 |
0.429 |
|
| 2004 |
Sobocinski KA, Thall PF, Bekele BN, Klein JP, Lennon S, Horowitz MM, Andersson B. Matched Pairs Analysis of IV vs. PO Busulfan as a Conditioning Agent Prior to Transplantation. Blood. 104: 349-349. DOI: 10.1182/Blood.V104.11.349.349 |
0.479 |
|
| 2003 |
Serna DS, Lee SJ, Zhang MJ, Baker kS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 3754-60. PMID 14551294 DOI: 10.1200/Jco.2003.03.133 |
0.459 |
|
| 2003 |
Marin D, Marktel S, Szydlo R, Klein JP, Bua M, Foot N, Olavarria E, Shepherd P, Kanfer E, Goldman JM, Apperley JF. Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure on interferon alfa. Lancet. 362: 617-9. PMID 12944062 DOI: 10.1016/S0140-6736(03)14182-7 |
0.349 |
|
| 2003 |
Butturini A, Klein J, Gale RP. Modeling minimal residual disease (MRD)-testing. Leukemia Research. 27: 293-300. PMID 12531219 DOI: 10.1016/S0145-2126(02)00166-2 |
0.305 |
|
| 2003 |
Tomas LHS, Loberiza FR, Klein JP, Layde PM, Lipchik RJ, Rizzo JD, Bredeson CN, Horowitz MM. Risk Factors for Bronchiolitis Obliterans in Allogeneic Bone Marrow Transplant Recipients for Leukemi Chest. 124. DOI: 10.1378/Chest.124.4_Meetingabstracts.109S |
0.428 |
|
| 2003 |
Andersen PK, Klein JP, Rosthøj S. Generalised linear models for correlated pseudo‐observations, with applications to multi‐state models Biometrika. 90: 15-27. DOI: 10.1093/Biomet/90.1.15 |
0.368 |
|
| 2003 |
Klein JP, Bajorunaite R. Inference for Competing Risks Handbook of Statistics. 23: 291-311. DOI: 10.1016/S0169-7161(03)23016-9 |
0.433 |
|
| 2003 |
Klein JP, Wu JT. Discretizing a Continuous Covariate in Survival Studies Handbook of Statistics. 23: 27-42. DOI: 10.1016/S0169-7161(03)23002-9 |
0.339 |
|
| 2002 |
Klein JP. Survival analysis methods in cancer studies. Cancer Treatment and Research. 113: 37-57. PMID 12613349 DOI: 10.1007/978-1-4757-3571-0_3 |
0.365 |
|
| 2002 |
Litzow MR, Pérez WS, Klein JP, Bolwell BJ, Camitta B, Copelan EA, Gale RP, Giralt SA, Keating A, Lazarus HM, Marks DI, McCarthy PL, Miller CB, Milone G, Prentice HG, et al. Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. British Journal of Haematology. 119: 1115-24. PMID 12472596 DOI: 10.1046/J.1365-2141.2002.03973.X |
0.518 |
|
| 2002 |
Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, Canals C, Boogaerts MA, Goldman J, Champlin RE, Keating A, et al. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood. 100: 1997-2004. PMID 12200358 DOI: 10.1182/Blood.V100.6.1997.H81802001997_1997_2004 |
0.517 |
|
| 2002 |
Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY, Carabasi MH, Gale RP, Giralt S, Hale GA, Ilhan O, McCarthy PL, Socie G, Verdonck LF, Weisdorf DJ, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood. 100: 406-14. PMID 12091329 DOI: 10.1182/Blood.V100.2.406 |
0.481 |
|
| 2002 |
Klein JP, Shu Y. Multi-state models for bone marrow transplantation studies. Statistical Methods in Medical Research. 11: 117-39. PMID 12040693 DOI: 10.1191/0962280202Sm277Ra |
0.663 |
|
| 2002 |
Weisdorf D, Bishop M, Dharan B, Bolwell B, Cahn JY, Cairo M, Giralt S, Klein J, Lazarus H, Litzow M, Marks D, McCarthy P, Miller C, Milone G, Russell J, et al. Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 8: 213-20. PMID 12014810 DOI: 10.1053/bbmt.2002.v8.pm12014810 |
0.408 |
|
| 2002 |
Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL, Norton L, Parnes H, et al. High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 743-50. PMID 11821456 DOI: 10.1200/Jco.20.3.743 |
0.412 |
|
| 2002 |
Drobyski WR, Klein J, Flomenberg N, Pietryga D, Vesole DH, Margolis DA, Keever-Taylor CA. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. Blood. 99: 806-14. PMID 11806980 DOI: 10.1182/Blood.V99.3.806 |
0.493 |
|
| 2002 |
Roudebush B, Klein J. Converting Clinical Literature to an Insured Population: A Comparison of Models Using Nhanes North American Actuarial Journal. 6: 55-65. DOI: 10.1080/10920277.2002.10596063 |
0.315 |
|
| 2001 |
Lee SJ, Klein JP, Anasetti C, Antin JH, Loberiza FR, Bolwell BJ, LeMaistre CF, Litzow MR, Marks D, Waller EK, Matlack M, Giralt S, Horowitz MM. The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase. Blood. 98: 3205-11. PMID 11719355 DOI: 10.1182/Blood.V98.12.3205 |
0.5 |
|
| 2001 |
Miller CB, Rowlings PA, Zhang MJ, Jones RJ, Piantadosi S, Keating A, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. Experimental Hematology. 29: 1336-46. PMID 11698130 DOI: 10.1016/S0301-472X(01)00732-9 |
0.439 |
|
| 2001 |
Zhang MJ, Klein JP. Confidence bands for the difference of two survival curves under proportional hazards model. Lifetime Data Analysis. 7: 243-54. PMID 11677829 DOI: 10.1023/A:1011636407958 |
0.403 |
|
| 2001 |
Keever-Taylor CA, Klein JP, Eastwood D, Bredeson C, Margolis DA, Burns WH, Vesole DH. Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose. Bone Marrow Transplantation. 27: 791-800. PMID 11477435 DOI: 10.1038/Sj.Bmt.1702872 |
0.345 |
|
| 2001 |
Keiding N, Klein JP, Horowitz MM. Multi-state models and outcome prediction in bone marrow transplantation. Statistics in Medicine. 20: 1871-85. PMID 11406847 DOI: 10.1002/Sim.810 |
0.414 |
|
| 2001 |
Juckett M, Cohen E, Keever-Taylor C, Zheng Y, Lawton C, Moulder J, Klein J. Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors. Bone Marrow Transplantation. 27: 451-456. PMID 11313676 DOI: 10.1038/Sj.Bmt.1702797 |
0.352 |
|
| 2001 |
Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ, Casper JT, Cowan MJ, Edwards JR, Fasth A, Gale RP, Junker A, Kamani NR, Loechelt BJ, Pietryga DW, ... ... Klein JP, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 97: 1598-603. PMID 11238097 DOI: 10.1182/Blood.V97.6.1598 |
0.502 |
|
| 2000 |
Klein JP, Szydlo RM, Craddock C, Goldman JM. Estimation of current leukaemia-free survival following donor lymphocyte infusion therapy for patients with leukaemia who relapse after allografting: application of a multistate model. Statistics in Medicine. 19: 3005-16. PMID 11042629 DOI: 10.1002/1097-0258(20001115)19:21<3005::Aid-Sim592>3.0.Co;2-9 |
0.478 |
|
| 2000 |
Stiff PJ, Veum-Stone J, Lazarus HM, Ayash L, Edwards JR, Keating A, Klein JP, Oblon DJ, Shea TC, Thomé S, Horowitz MM. High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. Annals of Internal Medicine. 133: 504-15. PMID 11015163 DOI: 10.7326/0003-4819-133-7-200010030-00009 |
0.437 |
|
| 2000 |
Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. The New England Journal of Medicine. 342: 1846-54. PMID 10861319 DOI: 10.1056/Nejm200006223422501 |
0.447 |
|
| 2000 |
Klein JP, Keiding N, Shu Y, Szydlo RM, Goldman JM. Summary curves for patients transplanted for chronic myeloid leukaemia salvaged by a donor lymphocyte infusion: the current leukaemia-free survival curve. British Journal of Haematology. 109: 148-52. PMID 10848794 DOI: 10.1046/J.1365-2141.2000.01982.X |
0.688 |
|
| 2000 |
Davies SM, Ramsay NK, Klein JP, Weisdorf DJ, Bolwell B, Cahn JY, Camitta BM, Gale RP, Giralt S, Heilmann C, Henslee-Downey PJ, Herzig RH, Hutchinson R, Keating A, Lazarus HM, et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 340-7. PMID 10637248 DOI: 10.1200/Jco.2000.18.2.340 |
0.409 |
|
| 2000 |
Craddock C, Szydlo RM, Klein JP, Dazzi F, Olavarria E, van Rhee F, Pocock C, Cwynarski K, Apperley JF, Goldman JM. Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission Blood. 96: 86-90. DOI: 10.1182/Blood.V96.1.86.013K54_86_90 |
0.49 |
|
| 2000 |
Giralt S, Szydlo R, Goldman JM, Veum-Stone J, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM. Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry Blood. 95: 410-415. DOI: 10.1182/Blood.V95.2.410 |
0.491 |
|
| 2000 |
Champlin RE, Passweg JR, Zhang MJ, Rowlings PA, Pelz CJ, Atkinson KA, Barrett AJ, Cahn JY, Drobyski WR, Gale RP, Goldman JM, Gratwohl A, Gordon-Smith EC, Henslee-Downey PJ, Herzig RH, ... Klein JP, et al. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood. 95: 3996-4003. DOI: 10.1182/Blood.V95.12.3996 |
0.421 |
|
| 2000 |
Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation Blood. 95: 3702-3709. DOI: 10.1182/Blood.V95.12.3702 |
0.491 |
|
| 2000 |
Johnson RA, Klein JP. 6 Regression models for survival data Handbook of Statistics. 18: 161-191. DOI: 10.1016/S0169-7161(00)18008-3 |
0.345 |
|
| 1999 |
Klein JP, Pelz C, Zhang MJ. Modeling random effects for censored data by a multivariate normal regression model. Biometrics. 55: 497-506. PMID 11318206 DOI: 10.1111/J.0006-341X.1999.00497.X |
0.341 |
|
| 1999 |
Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL, Herzig RH, Stadtmauer EA, Lazarus HM, et al. Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. Jama. 282: 1335-43. PMID 10527180 DOI: 10.1001/Jama.282.14.1335 |
0.384 |
|
| 1999 |
Andersen PK, Horowitz MM, Klein JP, Socie G, Stone JV, Zhang MJ. Modelling covariate adjusted mortality relative to a standard population. Statistics in Medicine. 18: 1529-40. PMID 10398290 DOI: 10.1002/(Sici)1097-0258(19990630)18:12<1529::Aid-Sim137>3.0.Co;2-J |
0.45 |
|
| 1999 |
Andersen PK, Klein JP, Zhang MJ. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Statistics in Medicine. 18: 1489-500. PMID 10398287 DOI: 10.1002/(Sici)1097-0258(19990630)18:12<1489::Aid-Sim140>3.0.Co;2-# |
0.363 |
|
| 1999 |
Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. The New England Journal of Medicine. 341: 14-21. PMID 10387937 DOI: 10.1056/Nejm199907013410103 |
0.502 |
|
| 1999 |
Mugishima H, Harada K, Chin M, Suzuki T, Takagi K, Hayakawa S, Sato K, Klein JP, Gale RP. Effects of long-term cryopreservation on hematopoietic progenitor cells in umbilical cord blood. Bone Marrow Transplantation. 23: 395-6. PMID 10100584 DOI: 10.1038/Sj.Bmt.1701580 |
0.319 |
|
| 1999 |
Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ, Gajewski JL, Gale RP, Keating A, Klein JP, Miller CB, Phillips GL, Reece DE, Sobocinski KA, van Besien K, et al. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 534-45. PMID 10080597 DOI: 10.1200/Jco.1999.17.2.534 |
0.42 |
|
| 1999 |
Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Keever-Taylor CA. T-Cell Depletion Plus Salvage Immunotherapy With Donor Leukocyte Infusions as a Strategy to Treat Chronic-Phase Chronic Myelogenous Leukemia Patients Undergoing HLA-Identical Sibling Marrow Transplantation Blood. 94: 434-441. DOI: 10.1182/Blood.V94.2.434 |
0.497 |
|
| 1999 |
Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Keever-Taylor CA. T-Cell Depletion Plus Salvage Immunotherapy With Donor Leukocyte Infusions as a Strategy to Treat Chronic-Phase Chronic Myelogenous Leukemia Patients Undergoing HLA-Identical Sibling Marrow Transplantation Blood. 94: 434-441. DOI: 10.1182/blood.V94.2.434 |
0.401 |
|
| 1999 |
Klein JP, Zhang M. Determining when the survival rates of two treatments are the same based on a censored data regression model Journal of Statistical Planning and Inference. 78: 243-254. DOI: 10.1016/S0378-3758(98)00217-1 |
0.427 |
|
| 1998 |
Passweg JR, Rowlings PA, Atkinson KA, Barrett AJ, Gale RP, Gratwohl A, Jacobsen N, Klein JP, Ljungman P, Russell JA, Schaefer UW, Sobocinski KA, Vossen JM, Zhang MJ, Horowitz MM. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplantation. 21: 1231-8. PMID 9674857 DOI: 10.1038/Sj.Bmt.1701238 |
0.508 |
|
| 1998 |
Waters TM, Bennett CL, Pajeau TS, Sobocinski KA, Klein JP, Rowlings PA, Horowitz MM. Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know? Bone Marrow Transplantation. 21: 641-50. PMID 9578302 DOI: 10.1038/Sj.Bmt.1701160 |
0.365 |
|
| 1998 |
Passweg JR, Tiberghien P, Cahn JY, Vowels MR, Camitta BM, Gale RP, Herzig RH, Hoelzer D, Horowitz MM, Ifrah N, Klein JP, Marks DI, Ramsay NK, Rowlings PA, Weisdorf DJ, et al. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplantation. 21: 153-8. PMID 9489632 DOI: 10.1038/Sj.Bmt.1701064 |
0.451 |
|
| 1998 |
Besien KV, Sobocinski KA, Rowlings PA, Murphy SC, Armitage JO, Bishop MR, Chaekal OK, Gale RP, Klein JP, Lazarus HM, McCarthy PL, Raemaekers JMM, Reiffers J, Phillips GL, Schattenberg AVMB, et al. Allogeneic bone marrow transplantation for low-grade lymphoma. Blood. 92: 1832-1836. DOI: 10.1182/Blood.V92.5.1832.417A04_1832_1836 |
0.5 |
|
| 1998 |
Gale RP, Hehlmann R, Zhang MJ, Hasford J, Goldman JM, Heimpel H, Hochhaus A, Klein JP, Kolb HJ, McGlave PB, Passweg JR, Rowlings PA, Sobocinski KA, Horowitz MM. Survival With Bone Marrow Transplantation Versus Hydroxyurea or Interferon for Chronic Myelogenous Leukemia Blood. 91: 1810-1819. DOI: 10.1182/Blood.V91.5.1810.1810_1810_1819 |
0.521 |
|
| 1997 |
Zhang MJ, Baccarani M, Gale RP, McGlave PB, Atkinson K, Champlin RE, Dicke KA, Giralt S, Gluckman E, Goldman JM, Klein JP, Herzig RH, Masaoka T, O'Reilly RJ, Rozman C, et al. Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. British Journal of Haematology. 99: 23-9. PMID 9359497 DOI: 10.1046/J.1365-2141.1997.3313150.X |
0.515 |
|
| 1997 |
Drobyski WR, Endean DJ, Klein JP, Hessner MJ. Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia. British Journal of Haematology. 98: 458-66. PMID 9266951 DOI: 10.1046/J.1365-2141.1997.2223039.X |
0.483 |
|
| 1997 |
Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, Cahn JY, Calderwood S, Gratwohl A, Socié G, Abecasis MM, Sobocinski KA, Zhang MJ, Horowitz MM. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. British Journal of Haematology. 97: 855-64. PMID 9217189 DOI: 10.1046/j.1365-2141.1997.1112925.x |
0.378 |
|
| 1997 |
Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL, Saez R, et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 15: 1870-9. PMID 9164197 DOI: 10.1200/Jco.1997.15.5.1870 |
0.327 |
|
| 1997 |
Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb HJ, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 15: 1767-77. PMID 9164184 DOI: 10.1200/Jco.1997.15.5.1767 |
0.449 |
|
| 1997 |
Hinterberger W, Rowlings PA, Hinterberger-Fischer M, Gibson J, Jacobsen N, Klein JP, Kolb HJ, Stevens DA, Horowitz MM, Gale RP. Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Annals of Internal Medicine. 126: 116-22. PMID 9005745 DOI: 10.7326/0003-4819-126-2-199701150-00004 |
0.389 |
|
| 1997 |
Keiding N, Andersen PK, Klein JP. The role of frailty models and accelerated failure time models in describing heterogeneity due to omitted covariates. Statistics in Medicine. 16: 215-24. PMID 9004393 DOI: 10.1002/(Sici)1097-0258(19970130)16:2<215::Aid-Sim481>3.0.Co;2-J |
0.353 |
|
| 1997 |
Andersen PK, Klein JP, Knudsen KM, y Palacios RT. Estimation of Variance in Cox's Regression Model with Shared Gamma Frailties Biometrics. 53: 1475. DOI: 10.2307/2533513 |
0.336 |
|
| 1997 |
Passweg JR, Socié G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM, Champlin RE, Gale RP, Gluckman E, Gordon-Smith EC, Hows JM, Klein JP, Nugent ML, Pasquini R, Rowlings PA, et al. Bone marrow transplantation for severe aplastic anemia: Has outcome improved? Blood. 90: 858-864. DOI: 10.1182/Blood.V90.2.858.858_858_864 |
0.504 |
|
| 1996 |
Gajewski JL, Phillips GL, Sobocinski KA, Armitage JO, Gale RP, Champlin RE, Herzig RH, Hurd DD, Jagannath S, Klein JP, Lazarus HM, McCarthy PL, Pavlovsky S, Peterson FB, Rowlings PA, et al. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 14: 572-8. PMID 8636773 DOI: 10.1200/Jco.1996.14.2.572 |
0.418 |
|
| 1996 |
Li YH, Klein JP, Moeschberger ML. Effects of model misspecification in estimating covariate effects in survival analysis for small sample sizes Computational Statistics and Data Analysis. 22: 177-192. DOI: 10.1016/0167-9473(96)88029-7 |
0.337 |
|
| 1995 |
Moeschberger ML, Klein JP. Statistical methods for dependent competing risks. Lifetime Data Analysis. 1: 195-204. PMID 9385101 DOI: 10.1007/Bf00985770 |
0.321 |
|
| 1995 |
Zhang MJ, Hoelzer D, Horowitz MM, Gale RP, Messerer D, Klein JP, Löffler H, Sobocinski KA, Thiel E, Weisdorf DJ. Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee. Annals of Internal Medicine. 123: 428-31. PMID 7639442 DOI: 10.7326/0003-4819-123-6-199509150-00006 |
0.434 |
|
| 1995 |
Zheng M, Klein JP. Estimates of marginal survival for dependent competing risks based on an assumed copula Biometrika. 82: 127-138. DOI: 10.1093/Biomet/82.1.127 |
0.346 |
|
| 1995 |
Wang ST, Klein JP, Moeschberger ML. Semi-parametric estimation of covariate effects using the positive stable frailty model Applied Stochastic Models and Data Analysis. 11: 121-133. DOI: 10.1002/Asm.3150110203 |
0.329 |
|
| 1994 |
Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA, Rimm AA, Klein JP, Shuster JJ, Sobocinski KA, Gale RP. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission New England Journal of Medicine. 331: 1253-1258. PMID 7935682 DOI: 10.1056/Nejm199411103311902 |
0.484 |
|
| 1994 |
Zheng M, Klein JP. A self-consistent estimator of marginal survival functions based on dependent competing risk data and an assumed copula Communications in Statistics - Theory and Methods. 23: 2299-2311. DOI: 10.1080/03610929408831387 |
0.328 |
|
| 1993 |
Klein JP, Keiding N, Copelan EA. Plotting summary predictions in multistate survival models: probabilities of relapse and death in remission for bone marrow transplantation patients. Statistics in Medicine. 12: 2315-32. PMID 8134735 DOI: 10.1002/Sim.4780122408 |
0.469 |
|
| 1992 |
Copelan EA, Biggs JC, Avalos BR, Szer J, Cunningham I, Klein JP, Atkinson K, Kapoor N, Klein JL, Downs K. Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 10: 237-42. PMID 1732424 DOI: 10.1200/Jco.1992.10.2.237 |
0.416 |
|
| 1992 |
Klein JP. Semiparametric Estimation of Random Effects Using the Cox Model Based on the EM Algorithm Biometrics. 48: 795. DOI: 10.2307/2532345 |
0.322 |
|
| 1991 |
Copelan E, Biggs J, Thompson J, Crilley P, Szer J, Klein J, Kapoor N, Avalos B, Cunningham I, Atkinson K. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2 Blood. 78: 838-843. DOI: 10.1182/Blood.V78.3.838.838 |
0.478 |
|
| 1990 |
Klein JP, Lee S, Moeschberger ML. A Partially Parametric Estimator of Survival in the Presence of Randomly Censored Data Biometrics. 46: 795. DOI: 10.2307/2532097 |
0.368 |
|
| 1989 |
Klein JP, Keiding N, Kamby C. Semiparametric Marshall-Olkin Models Applied to the Occurrence of Metastases at Multiple Sites after Breast Cancer Biometrics. 45: 1073. DOI: 10.2307/2531761 |
0.302 |
|
| 1988 |
Klein JP, Moeschberger ML. Bounds on Net Survival Probabilities for Dependent Competing Risks Biometrics. 44: 529. DOI: 10.2307/2531865 |
0.308 |
|
| 1987 |
Tutschka P, Copelan E, Klein J. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen Blood. 70: 1382-1388. DOI: 10.1182/Blood.V70.5.1382.Bloodjournal7051382 |
0.418 |
|
| 1985 |
Moeschberger ML, Klein JP. A Comparison of Several Methods of Estimating the Survival Function When There is Extreme Right Censoring Biometrics. 41: 253. DOI: 10.2307/2530660 |
0.302 |
|
| Show low-probability matches. |